AI assistant
Sending…
Bio Green Med Solution, Inc. — Director's Dealing 2016
May 31, 2016
35092_dirs_2016-05-31_1c6a1b3b-637a-409a-b81d-a7a3ddc16f5c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2016-05-26
Reporting Person: Bacopoulos Nicholas G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-26 | Option | $0.429 | A | 15000 | Acquired | 2026-05-26 | Common Stock (15000) | Direct |
Footnotes
F1: These options were granted to Dr. Bacopoulos for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.
More from Bio Green Med Solution, Inc.
Notice of Dividend Amount
2026
Jul 1
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 22
M&A Activity
2026
Jun 16
Capital/Financing Update
2026
Jun 10
M&A Activity
2026
Jun 4
M&A Activity
2026
Jun 4
Interim / Quarterly Report
2026
May 15
Notice of Dividend Amount
2026
Apr 13
Annual Report
2026
Mar 30
Notice of Dividend Amount
2026
Jan 12